Researchers are developing a two-component therapy for type 1 diabetes. The therapy consists of lab-made insulin-producing cells paired with custom-made immune cells. These immune cells protect the insulin-producing cells from being destroyed by the immune system. The goal is to achieve protection without the need for immunosuppressive drugs. The team received $1 million in funding. They hope to create a treatment ready for use in people with type 1 diabetes, including those who have had the disease for years. This approach could change the way type 1 diabetes is treated.